Z
ZBiotics
Synthetic biology company that bioengineers probiotic bacteria for nutraceutical and other applications
About ZBiotics
ZBiotics is a biotechnology company specializing in genetically engineered probiotics designed to break down acetaldehyde, a toxic byproduct of alcohol consumption. The company targets health-conscious consumers who seek to mitigate the negative effects of alcohol. Operating in the health and wellness market, ZBiotics employs a direct-to-consumer business model, selling its products primarily through its website. Revenue is generated through the sale of individual units and subscription plans. The company emphasizes transparency, responsibility, and a people-first approach, with ongoing research aimed at addressing other health challenges such as dairy intolerance, radiation exposure, and lead contamination in water.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- San Francisco, United States
- Employees
- 64
- Open positions
- 1
- Dealroom signal
- 84.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Alcohol, Biotech and Pharma, Hard Tech, YC W18, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2024 | $12M | $48M | Seaside Ventures · Goat Rodeo Capital · Seamless Capital · Access Capital | ↗ |
| SEED✓Equity / VC | Mar 2020 | $2.3M | $9.2M | Oyster Ventures · Oyster Ventures | ↗ |
Growth signals
Latest recorded traffic for ZBiotics is 220K monthly website visits, up 15.8% over the last three months. ZBiotics's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Khosla Ventures
Y Combinator
Oyster Ventures
Series A5 investors entered at this stage
Spring Tide Capital
Seaside Ventures
Goat Rodeo Capital
Seamless Capital- ACAccess Capital
Other known investors12 additional known investors
- APAble Partners
Champion Hill Ventures
Chris Lu
Edward Lando
Innovation Global Capital
Jordy Koski- KHKyle J. Hong
Litani Ventures- MGMurano Group
Plug and Play
Pure Ventures
Rose Steinberg
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ZBiotics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ZBiotics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







